Case Studies

  1. Phase IIb Trial: Evaluating A Novel Treatment For Locally Advanced Or Metastatic Breast Cancer 12/5/2024

    This case study highlights a successful Phase IIb clinical trial conducted by an Indian biotech company evaluating a novel treatment for Locally Advanced or Metastatic Breast Cancer.

  2. Muscular Dystrophy: Multi-National And Multi-Site Trials 10/15/2024

    Learn about the success ReveraGen found when expanding their partnership with Novotech to a larger phase 2b trial (VBP15-004) in Duchenne Muscular Dystrophy (DMD).

  3. Examining A Phase 1 COVID-19 Clinical Trial 5/10/2024

    Uncover how we were able to efficiently activate the site and enroll 130 participants within six months, demonstrating our expertise in clinical trial management.

  4. Advancing From Single Country Phase 1 Success To Multinational Phase 1/2 Trial 1/3/2024

    Explore how this partnership aims to contribute to the success of the trial by leveraging global resources and streamlining processes for efficient and timely results.

  5. Expert Consulting And MRCT Strategy Rescues Oncology Program 1/3/2024

    Uncover how this strategic approach yielded significant outcomes, including uncovering missing data through IB review, streamlining dosing timelines, and achieving successful recruitment milestones.

  6. From Phase I In Australia To A Global Phase III 5/8/2023

    With some help, see how one California-based biotech company was able to get its patients on treatment by the end of the fiscal year and identify additional opportunities to streamline processes and leverage document/process standards.

  7. Study Launches Early Phase In Australia With Later Expansion To China 5/8/2023

    Understand how a biotech company was able to facilitate clinical development plans to extend its study into China for Phase II component, as quickly as possible.

  8. Expert Consulting, MRCT Strategy Rescues Oncology Program 5/8/2023

    Uncover how teams identified missing IB data and necessary additional details needed to outline U.S. study challenges as required for local authority approval in a previously failing study.

  9. A Nimble And Flexible Solution To Rescuing An Observational Study 5/8/2023

    Uncover how a European biotech was able to accelerate site start-up and exceed patient recruitment goals at more than 145 sites in North America, Europe, and Asia Pacific (APAC).